TREANDA 25 mg Injection
RxNorm 1805009 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for TREANDA 25 mg Injection (RxCUI 1805009). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Cephalon, LLC 4

Cephalon, LLC

NDC Product
Human Prescription Drug

Treanda
NDC 63459-390

Generic Name
Bendamustine Hydrochloride
Dosage Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Treanda
NDC 63459-391

Generic Name
Bendamustine Hydrochloride
Dosage Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing
NDA
Active Listing
NDC Product

Treanda
NDC 63459-395

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
NDA
Active Listing
NDC Product

Treanda
NDC 63459-396

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
NDA
Active Listing